{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T19:10:02Z","timestamp":1749928202096,"version":"3.41.0"},"reference-count":24,"publisher":"Consilium Medicum","issue":"12","license":[{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. To study the rate of chronic glomerulonephritis progression when added by anemia and cardiovascular disease (CVD). Subjects and methods. 231 patients (133 men and 98 women) with predialysis chronic glomerulonephritis (CGN) were examined. The patients\u2019 mean age of was 35.8\u00b111.8 years; the disease duration was 1 to 17 years. The disease onset was the date when urinalysis showed evidence of persistent proteinuria and (or) hematuria. Besides, the time when anemia developed and the clinical and instrumental signs of CVD appeared was taken as the initial reference point; the time when end-stage renal failure was diagnosed was taken to be the endpoint. Red blood cell counts with the inclusion of its indices, hemoglobin concentration, hematocrit values, daily proteinuria values, and glomerular filtration rate were analyzed. The biochemical parameters included the concentrations of electrolytes, creatinine, fibrinogen, iron, cholesterol, total protein and C-reactive protein (CRP). Electrocardiography and echocardiography, bicycle ergometry and 24-hour ECG monitoring were used to detect CVD. Results. The presence of anemia and CVD in patients with predialysis CGN versus those without anemia and CVD was associated with an increase in the concentrations of CRP [36.2 and 12.6%; respectively; (p<\/jats:p>","DOI":"10.17116\/terarkh2016881257-61","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T14:59:26Z","timestamp":1485183566000},"page":"57-61","source":"Crossref","is-referenced-by-count":1,"title":["The role of renal anemia and cardiovascular disease in the progression of chronic glomerulonephritis"],"prefix":"10.26442","volume":"88","author":[{"given":"I T","family":"Murkamilov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I G","family":"Gordeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R R","family":"Kaliev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2016,12,15]]},"reference":[{"key":"ref1","unstructured":"\u041c\u0443\u0445\u0438\u043d \u041d.\u0410. \u0421\u043d\u0438\u0436\u0435\u043d\u0438\u0435 \u0441\u043a\u043e\u0440\u043e\u0441\u0442\u0438 \u043a\u043b\u0443\u0431\u043e\u0447\u043a\u043e\u0432\u043e\u0439 \u0444\u0438\u043b\u044c\u0442\u0440\u0430\u0446\u0438\u0438 \u043e\u0431\u0449\u0435\u043f\u043e\u043f\u0443\u043b\u044f\u0446\u0438\u043e\u043d\u043d\u044b\u0439 \u043c\u0430\u0440\u043a\u0435\u0440 \u043d\u0435\u0431\u043b\u0430\u0433\u043e\u043f\u0440\u0438\u044f\u0442\u043d\u043e\u0433\u043e \u043f\u0440\u043e\u0433\u043d\u043e\u0437\u0430. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432. 2007;6:5-10. http:\/\/www.mediasphera.ru\/journals\/terapevt"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009101017"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009060631"},{"key":"ref4","unstructured":"\u041c\u0443\u0445\u0438\u043d \u041d.\u0410., \u041c\u043e\u0438\u0441\u0435\u0435\u0432 \u0412.\u0421., \u041a\u043e\u0431\u0430\u043b\u0430\u0432\u0430 \u0416.\u0414. \u041c\u043e\u0438\u0441\u0435\u0435\u0432 \u0421.\u0412., \u0424\u043e\u043c\u0438\u043d \u0412.\u0412. \u041a\u0430\u0440\u0434\u0438\u043e\u0440\u0435\u043d\u0430\u043b\u044c\u043d\u044b\u0435 \u0432\u0437\u0430\u0438\u043c\u043e\u043e\u0442\u043d\u043e\u0448\u0435\u043d\u0438\u044f: \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u0437\u043d\u0430\u0447\u0435\u043d\u0438\u0435 \u0438 \u0440\u043e\u043b\u044c \u0432 \u043f\u0430\u0442\u043e\u0433\u0435\u043d\u0435\u0437\u0435 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439 \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u043e\u0439 \u0441\u0438\u0441\u0442\u0435\u043c\u044b \u0438 \u043f\u043e\u0447\u0435\u043a. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432. 2004;6:39-46. http:\/\/www.mediasphera.ru\/journals\/terapevt."},{"key":"ref5","unstructured":"\u0422\u043e\u043c\u0438\u043b\u0438\u043d\u0430 \u041d.\u0410., \u0412\u043e\u043b\u0433\u0438\u043d\u0430 \u0413.\u0412., \u0411\u0438\u043a\u0431\u043e\u0432 \u0411.\u0422. \u041a\u0438\u043c \u0418.\u0413. \u041f\u0440\u043e\u0431\u043b\u0435\u043c\u0430 \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u044b\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439 \u043f\u0440\u0438 \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043f\u043e\u0447\u0435\u0447\u043d\u043e\u0439 \u043d\u0435\u0434\u043e\u0441\u0442\u0430\u0442\u043e\u0447\u043d\u043e\u0441\u0442\u0438. \u041d\u0435\u0444\u0440\u043e\u043b\u043e\u0433\u0438\u044f \u0438 \u0434\u0438\u0430\u043b\u0438\u0437. 2003;5(1): 15-24. http:\/\/www.nephro.ru."},{"key":"ref6","unstructured":"\u0415\u043a\u0430\u0440\u0434 \u041a.\u0423. \u0421\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u044b\u0435 \u043f\u043e\u0441\u043b\u0435\u0434\u0441\u0442\u0432\u0438\u044f \u043f\u043e\u0447\u0435\u0447\u043d\u043e\u0439 \u0430\u043d\u0435\u043c\u0438\u0438 \u0438 \u0442\u0435\u0440\u0430\u043f\u0438\u044f \u044d\u0440\u0438\u0442\u0440\u043e\u043f\u043e\u044d\u0442\u0438\u043d\u043e\u043c. \u041d\u0435\u0444\u0440\u043e\u043b\u043e\u0433\u0438\u044f \u0438 \u0434\u0438\u0430\u043b\u0438\u0437. 2000;3:181-188. http:\/\/www.nephro.ru."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Foley RN, Parfrey PS, Morgan J, Barr\u00e9 PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int. 2000;58:1325-1335. PMID: 10972697.","DOI":"10.1046\/j.1523-1755.2000.00289.x"},{"key":"ref8","unstructured":"\u0411\u0438\u043a\u0431\u043e\u0432 \u0411.\u0422., \u041a\u0438\u0440\u0445\u043c\u0430\u043d \u0412.\u0412., \u0422\u043e\u043c\u0438\u043b\u0438\u043d\u0430 H.A. \u041f\u0440\u0435\u0434\u0438\u043a\u0442\u043e\u0440\u044b \u043b\u0435\u0442\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u0438\u0441\u0445\u043e\u0434\u0430 \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u043d\u0430 \u0433\u0435\u043c\u043e\u0434\u0438\u0430\u043b\u0438\u0437\u0435. \u041d\u0435\u0444\u0440\u043e\u043b\u043e\u0433\u0438\u044f \u0438 \u0434\u0438\u0430\u043b\u0438\u0437. 2004;4(2):154-163. http:\/\/www.nephro.ru."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000328037"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn653"},{"key":"ref11","unstructured":"\u0411\u0435\u043b\u0435\u043d\u043a\u043e\u0432 \u042e.\u041d., \u041c\u0430\u0440\u0435\u0435\u0432 \u0412.\u042e. \u041f\u0440\u0438\u043d\u0446\u0438\u043f\u044b \u0440\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e\u0439 \u043d\u0435\u0434\u043e\u0441\u0442\u0430\u0442\u043e\u0447\u043d\u043e\u0441\u0442\u0438. \u041c.; 2000:266. http:\/\/lib.ossn.ru\/journals\/RHFJ."},{"key":"ref12","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int. 2012;2:114-164. www.kidney-international.org."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J. 2001;22:1527-1560. PMID: 11492984.","DOI":"10.1053\/euhj.2001.2783"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.121468"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahl\u00f6f B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003;139:901. PMID: 14644892","DOI":"10.7326\/0003-4819-139-11-200312020-00008"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;200:1048-1056. PMID: 15814534","DOI":"10.1093\/ndt\/gfh813"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr160"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-012-0063-3"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Valderrabano F, Jofre R, Lopez-Gomez JM. Quality of life in end-stage renal disease patients. Am JKidney Dis. 2001;38(3);443-464. PMID: 11532675, S0272638601973688.","DOI":"10.1053\/ajkd.2001.26824"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.483"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Van Biesen W, De Bacquer D, Verbeke F, Delanghe J, Lameire N, Vanholder R. The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J. 2007;28(4):478-483.","DOI":"10.1093\/eurheartj\/ehl455"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2013080899"},{"key":"ref23","unstructured":"Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S, Zhang PY. Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci. 2014;18(19):2918-2926."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeu134"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32084\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T18:49:09Z","timestamp":1749926949000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/32084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,15]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,15]]}},"URL":"https:\/\/doi.org\/10.17116\/terarkh2016881257-61","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"type":"electronic","value":"2309-5342"},{"type":"print","value":"0040-3660"}],"subject":[],"published":{"date-parts":[[2016,12,15]]}}}